Recent advances in transgenic model development for Alzheimer's disease

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Alzheimer's disease (AD) research is hindered by the absence of small animal models that fully recapitulate its key pathological features.
• Transgenic technology offers a promising avenue to create such models by introducing genetic elements associated with AD pathogenesis.

Purpose of the Study:

• To review and compare various transgenic mouse models of Alzheimer's disease.
• To assess the suitability of these models for evaluating drugs aimed at causal AD treatments.

Main Methods:

• Review of existing literature on transgenic mouse models for Alzheimer's disease.
• Comparative analysis of different models based on introduced genetic factors and resulting pathologies.
• Evaluation of model applicability for preclinical drug testing.

Main Results:

• Several transgenic mouse models have been developed, each with specific genetic modifications and pathological hallmarks relevant to Alzheimer's disease.
• These models exhibit varying degrees of success in mimicking aspects of AD, such as amyloid plaques and neurofibrillary tangles.
• The suitability of each model for drug testing differs based on the specific pathological pathways they represent.

Conclusions:

• Transgenic mouse models are crucial for advancing Alzheimer's disease research and drug development.
• Careful selection of appropriate models is essential for the effective testing of potential causal therapies.
• Continued development and refinement of these models will accelerate the search for an Alzheimer's disease cure.